Cancer Care Disparities during the COVID-19 Pandemic: COVID-19 and Cancer Outcomes Study

Cancer Cell. 2020 Dec 14;38(6):769-770. doi: 10.1016/j.ccell.2020.10.023. Epub 2020 Nov 3.

Authors

Andrew L Schmidt¹, Ziad Bakouny¹, Sheena Bhalla², John A Steinharter¹, Douglas A Tremblay², Mark M Awad¹, Alaina J Kessler², Robert I Haddad¹, Michelle Evans³, Fiona Busser¹, Michael Wotman³, Catherine R Curran¹, Brittney S Zimmerman², Gabrielle Bouchard¹, Tomi Jun², Pier V Nuzzo¹, Qian Qin², Laure Hirsch¹, Jonathan Feld², Kaitlin M Kelleher¹, Danielle Seidman², Hsin-Hui Huang², Heather M Anderson-Keightly², Sarah Abou Alaiwi¹, Talia D Rosenbloom², Penina S Stewart², Matthew D Galsky², Toni K Choueiri¹, Deborah B Doroshow⁴

Affiliations

¹ Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215, USA.
² Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, NY 10029, USA.
³ Department of Medicine, Icahn School of Medicine at Mount Sinai Hospital, New York, NY 10029, USA.
⁴ Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, NY 10029, USA. Electronic address: deborah.doroshow@mssm.edu.

No abstract available

Publication types

Letter
Multicenter Study

MeSH terms

Adult
Aged
Aged, 80 and over
COVID-19 / diagnosis
COVID-19 / epidemiology
COVID-19 / prevention & control*
COVID-19 / transmission
Communicable Disease Control / standards
Female
Follow-Up Studies
Healthcare Disparities / statistics & numerical data*
Humans
Male
Medical Oncology / organization & administration*
Medical Oncology / standards
Medical Oncology / statistics & numerical data
Middle Aged
Neoplasms / therapy*
Pandemics / prevention & control
Prospective Studies
SARS-CoV-2 / isolation & purification
SARS-CoV-2 / pathogenicity
Telemedicine / organization & administration*
Telemedicine / standards
Telemedicine / statistics & numerical data
Time Factors
Time-to-Treatment
Young Adult